Moss Adams Wealth Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Moss Adams Wealth Advisors's VRTX Position: Q2 2026 in Review
Moss Adams Wealth Advisors increased its Vertex Pharmaceuticals (VRTX) stake by 9.9% in Q2 2026, buying an estimated $42.1K and bringing the position to 1,052 shares worth $523K. The position accounts for 0.03% of the portfolio, ranked #146.
Moss Adams Wealth Advisors first reported a position in VRTX in Q2 2024 and has held it in 9 quarters since. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Moss Adams Wealth Advisors held 1,052 shares of Vertex Pharmaceuticals worth $523K as of Q2 2026.
- Moss Adams Wealth Advisors bought 95 Vertex Pharmaceuticals shares in Q2 2026, an estimated $42.1K.
- Vertex Pharmaceuticals made up 0.03% of Moss Adams Wealth Advisors's portfolio in Q2 2026, its #146 holding.
- Moss Adams Wealth Advisors first reported a position in Vertex Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
- 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Moss Adams Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.